Key result
Metabolic syndrome linked to ~86% higher MI risk alongside increased stroke and CV death.
Why the study?
Previous studies on the importance of metabolic syndrome as a cardiovascular risk factor had not focused on older Chinese adults.
Does metabolic syndrome increase the risk of carotid atherosclerosis and cardiovascular events in community-dwelling older Chinese adults?
Cohort (n=1,257)
Does metabolic syndrome increase the risk of carotid atherosclerosis and cardiovascular events in community-dwelling older Chinese adults?
Metabolic syndrome is independently associated with increased risks of carotid atherosclerosis, myocardial infarction, stroke, and cardiovascular mortality in older Chinese adults.
Answers are grounded in this paper and cite their sources.
MS associated with carotid atherosclerosis and CV events in older Chinese adults; leaves open whether targeting MS improves outcomes.
BACKGROUND AND OBJECTIVES: Previous studies on the importance of metabolic syndrome (MS) as a cardiovascular risk factor had not focused on older Chinese adults. The present study analyzed the association of MS with carotid atherosclerosis and the risk of cardiovascular events in Chinese adults. METHODS AND STUDY DESIGN: Data of a representative cohort study with 5-year follow-up were used. Community-dwelling people (n=1257) aged ≥55 years without cardiovascular disease (CVD) at baseline were followed up from 2009 to 2014. MS was defined based on the Chinese Diabetes Society criteria under the Chinese Medical Association. Multiple regression analyses were performed to examine the associations of MS with atherosclerosis and CVD events, with adjustment for confounding factors. RESULTS: In a multivariate logistic regression model with adjustment, MS was closely related to common carotid artery intima-media thickness (CCA-IMT) (1.62; 95% CI: 1.19-2.21) and carotid plaque presence (1.38; 95% CI: 1.01-1.89), but not with carotid artery stenosis. At the end of the 5-year follow- up, compared with subjects without MS, hazard ratios and 95% confidence intervals for the different risks in subjects with MS were 1.86 (1.02-3.29) for myocardial infarction (MI), 1.39 (1.01-2.05) for stroke, 1.52 (1.02- 2.37) for CVD death, and 1.13 (0.62-2.58) for total death, after adjusting for age, gender, smoking, drinking, physical activity, uric acid, high-sensitivity C-reactive protein, dietary factors and carotid atherosclerosis status. CONCLUSIONS: MS was significantly associated with IMT and the presence of carotid plaque and with positively increased risks of MI, stroke, and CVD mortality independent of CVD risk factors in older Chinese adults.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2019) conducted a cohort in Metabolic syndrome (n=1,257). Metabolic syndrome vs. Subjects without metabolic syndrome was evaluated on Myocardial infarction (MI) (HR 1.86, 95% CI 1.02-3.29). Metabolic syndrome was significantly associated with increased risks of myocardial infarction (HR 1.86; 95% CI 1.02-3.29), stroke, and cardiovascular death in older Chinese adults over 5 years.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: